Five UK organizations are calling for further discussions about the potential use of gene editing technologies such as CRISPR/Cas-9 for human germline editing, even as some are calling for a ban on the technology for such purposes.  

In a statement issued today, the organizations say that while UK law prohibits germline editing for clinical purposes, "there may be future potential to apply genome editing in a clinical context using human germ cells or embryos." 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.